In:
Microbiology and Immunology, Wiley, Vol. 64, No. 4 ( 2020-04), p. 296-303
Abstract:
The replicon system, which mimics viral genome replication in culture cells, has been widely used to analyze the genome replication of the hepatitis C virus (HCV). However, most HCV genomes used in the system include adaptive mutations (AMs) that are vital for replication in culture cells despite the nonexistence of such mutations in the genome of wild‐type (WT) HCV in patients. In order to study the genome replications of WT HCV, new HCV subgenomic replicon (SGR) systems were established using Huh‐7.5‐derived cells producing Sec14‐like protein 2 constitutively and SGR of KT9 (one of the HCV genotype 1b clones) with WT genome (SGR KT9WT) in this study. The replication efficiency and sensitivities of SGR KT9WT to anti‐HCV drugs in the cloned cells permanently bearing replicon RNA, HS55‐4 cells, were similar to those of reports using SGR, including AM. The SGR transient transfection system using SGR KT9WT and SGR KT9AM encoding secreted Nano‐luciferase and HS55‐4C cells established by the elimination of SGR KT9 RNA from HS55‐4 cells, however, showed that the replication efficiency of SGR KT9WT was much lower than that of SGR KT9AM under a same condition. Furthermore, the sensitivities of SGR KT9WT to almost all tested anti‐HCV reagents, except the inhibitor of miR‐122, a cellular factor important for HCV replication, were quite low compared with SGR KT9AM. These results suggested that the new replicon systems might not only provide information about precise responses against new anti‐HCV drugs but also reveal novel molecular mechanisms supporting negligent proliferation of HCV.
Type of Medium:
Online Resource
ISSN:
0385-5600
,
1348-0421
DOI:
10.1111/1348-0421.12768
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
2102145-4
SSG:
12
Bookmarklink
